BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12606578)

  • 1. HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin.
    Morita M; Ohneda O; Yamashita T; Takahashi S; Suzuki N; Nakajima O; Kawauchi S; Ema M; Shibahara S; Udono T; Tomita K; Tamai M; Sogawa K; Yamamoto M; Fujii-Kuriyama Y
    EMBO J; 2003 Mar; 22(5):1134-46. PubMed ID: 12606578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient exposure of rat pups to hyperoxia at normobaric and hyperbaric pressures does not cause retinopathy of prematurity.
    Calvert JW; Zhou C; Zhang JH
    Exp Neurol; 2004 Sep; 189(1):150-61. PubMed ID: 15296845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
    Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired expression of HIF-2α induces compensatory expression of HIF-1α for the recovery from anemia.
    Tsuboi I; Yamashita T; Nagano M; Kimura K; To'a Salazar G; Ohneda O
    J Cell Physiol; 2015 Jul; 230(7):1534-48. PubMed ID: 25557133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.
    Chen J; Connor KM; Aderman CM; Willett KL; Aspegren OP; Smith LE
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1329-35. PubMed ID: 18952918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia rapidly activates HIF-3alpha mRNA expression.
    Heidbreder M; Fröhlich F; Jöhren O; Dendorfer A; Qadri F; Dominiak P
    FASEB J; 2003 Aug; 17(11):1541-3. PubMed ID: 12824304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat.
    van Wijngaarden P; Brereton HM; Gibbins IL; Coster DJ; Williams KA
    Exp Eye Res; 2007 Oct; 85(4):508-17. PubMed ID: 17692314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIF-1α siRNA reduces retinal neovascularization in a mouse model of retinopathy of prematurity].
    Xu HZ; Liu SZ; Xiong SQ; Xia XB
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):680-3. PubMed ID: 21849124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
    DeNiro M; Alsmadi O; Al-Mohanna F
    Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced mitogenic factor has antiapoptotic action and is upregulated in the developing lung: coexpression with hypoxia-inducible factor-2alpha.
    Wagner KF; Hellberg AK; Balenger S; Depping R; Dodd-O J; Johns RA; Li D
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):276-82. PubMed ID: 15117738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha.
    Hara S; Hamada J; Kobayashi C; Kondo Y; Imura N
    Biochem Biophys Res Commun; 2001 Oct; 287(4):808-13. PubMed ID: 11573933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
    Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of mRNA of vascular endothelial growth factor in a rat model of hyperoxia-induced retinopathy].
    Zhang ZH; Jiang L; Qiao LX
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):371-4. PubMed ID: 17706045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock.
    Takahata S; Sogawa K; Kobayashi A; Ema M; Mimura J; Ozaki N; Fujii-Kuriyama Y
    Biochem Biophys Res Commun; 1998 Jul; 248(3):789-94. PubMed ID: 9704006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated erythropoietin mRNA and protein concentrations in the developing human eye.
    Patel S; Rowe MJ; Winters SA; Ohls RK
    Pediatr Res; 2008 Apr; 63(4):394-7. PubMed ID: 18356745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
    Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.